Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
69.93M | 95.47M | 113.65M | 103.13M | 133.43M | Gross Profit |
9.42M | 14.69M | 24.40M | 20.30M | 25.07M | EBIT |
-28.30M | -19.62M | -2.96M | -12.54M | -14.84M | EBITDA |
-19.95M | -9.36M | 3.55M | -3.62M | -1.41M | Net Income Common Stockholders |
-28.44M | -20.50M | -4.45M | -12.54M | -15.51M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
9.78M | 4.96M | 19.11M | 23.65M | 31.27M | Total Assets |
52.52M | 32.81M | 49.36M | 54.64M | 71.26M | Total Debt |
30.93M | 11.29M | 11.69M | 13.27M | 14.51M | Net Debt |
21.15M | 6.33M | -7.43M | -10.37M | -16.76M | Total Liabilities |
45.38M | 33.49M | 29.54M | 30.37M | 34.45M | Stockholders Equity |
7.32M | -680.82K | 19.82M | 24.27M | 36.81M |
Cash Flow | Free Cash Flow | |||
-36.76M | -6.46M | 4.26M | 1.67M | 2.20K | Operating Cash Flow |
-32.84M | -511.57K | 5.96M | 5.07M | 2.47M | Investing Cash Flow |
2.00M | -3.86M | -1.66M | -3.20M | 1.25M | Financing Cash Flow |
35.66M | -9.78M | -8.83M | -9.49M | -8.97M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | HK$655.60M | 13.27 | 13.35% | ― | 13.53% | 21.12% | |
72 Outperform | HK$42.66M | ― | -6.39% | ― | 14.00% | -366.00% | |
66 Neutral | $4.48B | 12.26 | 5.32% | 248.53% | 4.10% | -12.36% | |
51 Neutral | HK$1.29B | ― | -7.49% | ― | -3.22% | 55.08% | |
45 Neutral | HK$46.92M | ― | ― | -16.98% | 62.42% | ||
42 Neutral | HK$24.35M | ― | -818.26% | ― | 93.85% | 66.62% |